Prednisona, azatriopina y NAC en Fibrosis Pulmonar

CONCLUSIONS
Increased risks of death and hospitalization were observed in patients with idiopathic pulmonary fibrosis who were treated with a combination of prednisone, azathioprine, and NAC, as compared with placebo. These findings provide evidence against the use of this combination in such patients.

En NEJM

Informe del NIH